Authors

• Junnan Xu (ORCID: https://orcid.org/0000-0001-9044-8455)
• Jie Wu (ORCID: https://orcid.org/0000-0003-0935-342X)
• Luo Xu (ORCID: https://orcid.org/0000-0003-2004-023X)
• Xiaorui Li (ORCID: https://orcid.org/0009-0007-5268-0166)
• Yujun Jiang (ORCID: https://orcid.org/0000-0002-2857-2137)
• Yangyang Duan (ORCID: https://orcid.org/0000-0002-0823-6574)
• Fangyuan Dong
• Xiangyu Guo (ORCID: https://orcid.org/0000-0001-9699-8669)
• Zhichao Gao (ORCID: https://orcid.org/0000-0002-3604-107X)
• Cui Jiang (ORCID: https://orcid.org/0000-0002-4789-8386)
• Tao Sun (ORCID: https://orcid.org/0000-0001-8062-3432)
• Yufeng Jia
• Mingxi Jing
• Min Yan (ORCID: https://orcid.org/0000-0002-5184-9210)
• Yan Wang (ORCID: https://orcid.org/0000-0002-5344-1884)
• Zhaohui Li (ORCID: https://orcid.org/0000-0003-4286-7772)
• Kai Li (ORCID: https://orcid.org/0000-0002-8782-0823)
• Man Li (ORCID: https://orcid.org/0000-0003-4047-7543)
• Liang Zhang (ORCID: https://orcid.org/0000-0003-3100-8593)
• Yuyang Dong (ORCID: https://orcid.org/0000-0001-7112-5212)
• Huan Li (ORCID: https://orcid.org/0009-0005-1608-3087)
• Lei Jiang (ORCID: https://orcid.org/0009-0001-8623-0098)
• Zheng Lv
• Zhanhong Chen (ORCID: https://orcid.org/0000-0003-1802-6375)
• Hui Cao (ORCID: https://orcid.org/0000-0002-6470-9209)
• Quchang Ouyang (ORCID: https://orcid.org/0000-0003-1233-6081)
• Er‐Bo Ying

Institutions

• Jilin University (CN)
• Zhengzhou University (CN)
• Zhejiang Cancer Hospital (CN)
• Hunan Cancer Hospital (CN)
• First Hospital of Jilin University (CN)
• Henan Cancer Hospital (CN)
• Liaoning Cancer Hospital & Institute (CN)
• Anshan Hospital (CN)
• China Medical University (CN)

Publication Details

Journal

Frontiers in Oncology

Published

2025-09-02

DOI

https://doi.org/10.3389/fonc.2025.1496371

Citations

1

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

1.05